LogoPeqSERPE
logoCabeceraNinos

Hemos leído sobre ... Vacunación en enf. reumáticas

Última actualización: 3 agosto 2020
 
 
JULIO 2020
  • Rotstein Grein IH, Pinto NF, Lobo A, Groot N, Sztajnbok F, da Silva CAA, Paim Marques LB, Appenzeller S, Islabão AG, Magalhães CS, de Almeida RG, Bica B, Fraga M, da Fraga ACM, Dos Santos MC, Robazzi T, Terreri MTR, Bandeira M, Pasmans H, Schepp R, van der Klis F, de Roock S, Wulffraat N, Pileggi G.
    Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study.
    Lupus. 2020 Jul;29(8):934-942. doi: 10.1177/0961203320928406. Epub 2020 Jun 5.
    https://pubmed.ncbi.nlm.nih.gov/32501172/

 
MAYO 2020
 
MARZO 2020
  • Nakafero G, Grainge MJ, Myles PR, Mallen CD, Zhang W, Doherty M, Nguyen-Van-Tam JS, Abhishek A.
    Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs.
    Rheumatology (Oxford). 2020 Mar 11. pii: keaa078. doi: 10.1093/rheumatology/keaa078. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32160295
 
FEBRERO 2020
  • Bizjak M, Blazina Š, Zajc Avramovic M, Markelj G, Avcin T, Toplak N.
    Vaccination coverage in children with rheumatic diseases.
    Clin Exp Rheumatol. 2020 Jan-Feb;38(1):164-170. Epub 2019 Oct 2.
    https://www.ncbi.nlm.nih.gov/pubmed/31577215
  • Brunner HI, Tzaribachev N, Cornejo GV, Joos R, Gervais E, Cimaz R, Calvo Penadés I, Cuttica R, Lutz T, Quartier P, Gandhi Y, Nys M, Wong R, Martini A, Lovell DJ, Ruperto N; Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation.
    Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2-5?years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept.
    Pediatr Rheumatol Online J. 2020 Feb 22;18(1):19. doi: 10.1186/s12969-020-0410-x.
    https://www.ncbi.nlm.nih.gov/pubmed/32087715
 
ENERO 2020
  • Uziel Y, Moshe V, Onozo B, Kulcsár A, Tróbert-Sipos D, Akikusa JD, Salviato Pileggi G, Maritsi D, Kasapcopur O, Rodrigues M, Smerla R, Rigante D, Makay B, Atsali E, Wulffraat N, Toplak N; PReS working party of Vaccination Study Group.
    Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection.
    Vaccine. 2020 Jan 24. pii: S0264-410X(20)30052-9. doi: 10.1016/j.vaccine.2020.01.037. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/31987692
 
JULIO 2019
  •  Qendro T, de la Torre ML, Panopalis P, Hazel E, Ward BJ, Colmegna I, Hudson M.
    Suboptimal immunization coverage among Canadian rheumatology patients in routine clinical care.
    J Rheumatol. 2019 Jul 15. pii: jrheum.181376. doi: 10.3899/jrheum.181376. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/?term=31308211
 
MARZO 2018
  • Speth F, Hinze CH, Andel S, Mertens T, Haas JP.
    Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list.
    Pediatr Rheumatol Online J. 2018 Mar 2;16(1):15.
    https://www.ncbi.nlm.nih.gov/pubmed/29499726

     

  • Jeyaratnam J, Ter Haar NM, Lachmann HJ, Kasapcopur O, Ombrello AK, Rigante D, Dedeoglu F, Baris EH, Vastert SJ, Wulffraat NM, Frenkel J.
    The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey.
    Pediatr Rheumatol Online J. 2018 Mar 21;16(1):19. doi: 10.1186/s12969-018-0235-z.
    https://www.ncbi.nlm.nih.gov/pubmed/29562920
PATROCINADORES